Afrin S Z, Paul S K, Begum J A, Nasreen S A, Ahmed S, Ahmad F U, Aziz M A, Parvin R, Aung M S, Kobayashi N
Department of Microbiology, Mymensingh Medical College, Mymensingh, Bangladesh.
Department of Microbiology, Netrokona Medical College, Netrokona, Bangladesh.
New Microbes New Infect. 2021 May;41:100889. doi: 10.1016/j.nmni.2021.100889. Epub 2021 Apr 24.
In Bangladesh, coronavirus disease 2019 (COVID-19) has been highly prevalent during late 2020, with nearly 500 000 confirmed cases. In the present study, the spike (S) protein of severe acute respiratory coronavirus 2 (SARS-CoV-2) circulating in Bangladesh was genetically investigated to elucidate the diversity of mutations and their prevalence. The nucleotide sequence of the S protein gene was determined for 15 SARS-CoV-2 samples collected from eight divisions in Bangladesh, and analysed for mutations compared with the reference strain (hCoV-19/Wuhan/WIV04/2019). All the SARS-CoV-2 S genes were assigned to B.1 lineage in G clade, and individual S proteins had 1-25 mutations causing amino acid substitution/deletion. A total of 133 mutations were detected in 15 samples, with D614G being present in all the samples; 53 were novel mutations as of January 2021. On the receptor-binding domain, 21 substitutions including ten novel mutations were identified. Other novel mutations were located on the N-terminal domain (S1 subunit) and dispersed sites in the S2 subunit, including two substitutions that remove potential N-glycosylation sites. A P681R substitution adjacent to the furin cleavage site was detected in one sample. All the mutations detected were located on positions that are functionally linked to host transition, antigenic drift, host surface receptor binding or antibody recognition sites, and viral oligomerization interfaces, which presumably related to viral transmission and pathogenic capacity.
在孟加拉国,2019冠状病毒病(COVID-19)在2020年末高度流行,确诊病例近50万例。在本研究中,对在孟加拉国传播的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突(S)蛋白进行了基因研究,以阐明突变的多样性及其流行情况。测定了从孟加拉国八个分区收集的15份SARS-CoV-2样本的S蛋白基因的核苷酸序列,并与参考毒株(hCoV-19/武汉/WIV04/2019)进行比较分析突变情况。所有SARS-CoV-2 S基因均被归入G分支的B.1谱系,单个S蛋白有1至25个导致氨基酸替代/缺失的突变。在15个样本中总共检测到133个突变,所有样本中均存在D614G;截至2021年1月,有53个是新突变。在受体结合域,鉴定出21个替代,包括10个新突变。其他新突变位于N端结构域(S1亚基)和S2亚基的分散位点,包括两个去除潜在N糖基化位点的替代。在一个样本中检测到弗林蛋白酶切割位点附近的P681R替代。检测到的所有突变均位于与宿主转换、抗原漂移、宿主表面受体结合或抗体识别位点以及病毒寡聚化界面功能相关的位置,这可能与病毒传播和致病能力有关。